Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide Synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 2, 2011, Pages 183-188

  Sanli, Oner ^a   Kucukgergin, Canan ^a   Gokpinar, Murat ^a   Tefik, Tzevat ^a   Nane, Ismet ^a   Seckin, Sule ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Endothelium; Nitric oxide; Polymorphism; Prostate cancer

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; PROTEIN ENOS 4 A; PROTEIN ENOS 4 B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; BONE METASTASIS; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; ALLELES; BONE NEOPLASMS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 79952041582     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.04.011     Document Type: Article

References (29)

1. Chan J.M., Jou R.M., Carroll P.R. The relative impact and future burden of prostate cancer in the United States. J Urol 2004, 172:13-16.
2. Lu J., Wei Q., Bondy M.L., et al. Promoter polymorphism (-786t > C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 2006, 107:2245-2253.
3. Yoon S., Moon J., Shin C., et al. Smoking status-dependent association of the 27-bp repeat polymorphism in intron 4 of endothelial nitric oxide synthase gene with plasma nitric oxide concentrations. Clin Chim Acta 2002, 324:113-120.
4. Tsukada T., Yokoyama K., Arai T., et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998, 245:190-193.
5. Jadeski L.C., Chakraborty C., Lala P.K. Nitric oxide-mediated promotion of mammary tumor cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen activated protein kinase. Int J Cancer 2003, 106:496-504.
6. Dyke S.O., Moore A.M., et al. Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma. Cancer Res 2004, 64:152-161. Hu De.
7. Mederios R., Morais A., Vasconcelos A., et al. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev 2002, 11:343-350.
8. Miller S.A., Dykes D.D., Polesky H.S. Simples salting-out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1998, 20:1433-1440.
9. Wang X.L., Sim A.S., Badenhop R.F., et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996, 2:41-45.
10. Dhar A., Brindley J.M., Stark C., et al. Nitric oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther 2003, 12:1285-1293.
11. Simeone A.M., Colella S., Krahe R., et al. N-(4-hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. Carcinogenesis 2006, 27:568-577.
12. Fabbri F., Brigliadori G., Ulivi P., et al. Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells. Apoptosis 2005, 10:1095-1103.
13. Ying L., Hofseth L.J. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 2007, 67:1407-1410.
14. Lala P.K., Chakraborty C. Role of nitric oxide in carcinogenesis and tumor progression. Lancet Oncol 2001, 2:149-156.
15. Jadeski L.C., Chakraborty C., Lala P.K. Role of nitric oxide in tumor progression with special reference to a murine breast cancer model. Can J Physiol Pharmacol 2002, 8:125-135.
16. Qian J., Jenkins R.B., Bostwick D.G. Genetic and Chromosomal Alterations in Prostatic Intraepithelial Neoplasia and Carcinoma Detected by Fluorescence in situ Hybridization. Eur Urol 1999, 35:479-483.
17. Alberti C. Genetic and microenvironmental implications in prostate cancer progression and metastasis. Eur Rev Med Pharmacol Sci 2008, 12:167-175.
18. Ambs S., Merriam W.G., Bennet W.P., et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implications for tumor angiogenesis and colon cancer prevention. Cancer Res 1998, 58:2081-2085.
19. Lala P.K. Significance of nitric oxide in carcinogenesis, tumor progression, and cancer therapy. Cancer Metastasis Rev 1998, 17:1-6.
20. Mederios R., Morais A., Vasconcelos A., et al. Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumor cells in the blood of prostate cancer patients. Cancer Lett 2003, 189:85-90.
21. Song J., Yoon Y., Park K.U., et al. Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations and enzyme activity in cultured human endothelial cells. Clin Chem 2003, 49:847-852.
22. Riener E.K., Hefler L.A., Grimm C., et al. Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol 2004, 93:686-690.
23. Cheon K.T., Choi K.H., Lee H.B., et al. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000, 178:351-360.
24. Wei X.M., Kim H.S., Kumar R.K., et al. Effects of cigarette smoke on degranulation and NO production by mast cells and epithelial cells. Respir Res 2005, 6:108.
25. Su Y., Han W., Giraldo C., et al. Effect of cigarette smoking extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1998, 19:819-825.
26. Mederios R.M., Morais A., Vasconcelos A., et al. Outcome in prostate cancer. Association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin Cancer Res 2002, 8:3433-3437.
27. Marangoni K., Araujo T.G., Neves A.F., et al. The -786 > C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression. BMC Cancer 2008, 8:273-288.
28. Gradini R., Realacci M., Ginepri A., et al. Nitric oxide synthases in normal and benign hyperplastic human prostate immunohistochemistry and molecular biology. J Pathol 1999, 189:224-229.
29. Thompson I.M., Pauler D.K., Goodman P.J., et al. N Engl J Med 2004, 350:2239-2246.